Alzheimer's disease (AD), a common neurodegenerative brain disease, is mainly characterized by extracellular amyloid-beta (Aβ) plaque deposition and intracellular neurofibrillary tangles of phosphorylated tau protein, resulting in the loss of brain neurons. In recent years, Aβ peptide oligomerization has attracted much attention due to its effect on AD. In addition to various techniques, Creative Biolabs has developed various cell models such as AD in vitro models to facilitate better results. Creative Biolabs is committed to providing a diverse range of Aβ peptide oligomerization assay services to meet your specific needs. Learn more about Amyloid-beta Peptide Oligomerization Assay: https://neuros.creative-biolabs.com/amyloid-beta-peptide-oligomerization-assay.htm